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Introduction: Most studies on HF epidemiology have been performed
in western countries, and scarce data are available in Arab populations
including Saudi Arabia.
Objectives: In this study we aimed to determine the frequency of risk
factors and aetiologies for HF in patients admitted with acute heart
failure (AHF) to a tertiary care referral center in Riyadh, Saudi
Arabia.
Methods: We enrolled all consecutive patients admitted to our center
between September 2009 to December 2011 with the primary diagnosis
of acute heart failure. It is a prospective cohort study of the risk factors
and aetiologies leading to heart failure in that population. Relevant
information regarding the risk factors and aetiologies of HF were
recorded on CRF designed in accordance with the objectives of the
study.
Results: We enrolled 882 patients with median age (IQR) of 59 (15)
years; 68% men, 95% Saudis; 30% had de novo HF, and 72.3%
had reduced ejection fraction. Exacerbating factors for AHF admis-
sion were multifactorial including acute coronary syndrome (ACS) in
35.5% of patients, uncontrolled hypertension in 19.6%, infections in
13.8%, worsening renal failure in 34.3%, noncompliance with diet in
58.8%, and with treatment of HF in 19.3%. The main aetiologies of
HF were CAD (59.3%), idiopathic dilated cardiomyopathy (20.6%),
hypertension (8.2%), primary valvular heart disease (7.6%), cardiotox-
ic cardiomyopathy (2.5), pregnancy related cardiomyopathy (1%) and
thyroid disorder related cardiomyopathy (1%). The prevalence of cor-
onary artery disease (CAD) risk factors was high: 62.9% had diabetes
mellitus, 68.7% had hypertension, 44.2% were either current or ex-
smokers, and 36.4% had hyperlipidaemia.
Conclusions: Coronary artery disease, hypertension, cardiomyopathy
and valvular heart disease are the major contributors to heart failure
in this patient’s cohort. The exacerbating factors for acute heart fail-
ure included high rate of noncompliance to either heart failure diet or
medications which remains as a potential target for improvement of
care.
http://dx.doi.org/10.1016/j.ehj.2013.12.034
Impact of successful percutaneous balloon mitral valvuloplasty on pul-
monary vascular resistance and right ventricular functions
Mohammad Gouda Mohammad.
Background: Mitral stenosis (MS) still results in signiﬁcant morbidity
and mortality worldwide. Percutaneous balloon mitral “valvuloplasty”
commissurotomy (PMC) as invasive, nonsurgical procedure is safe and
eﬀective therapeutic modality in selected patients with rheumatic MS.
Right ventricular (RV) function abnormalities play an important role
in the development of clinical symptoms and the overall prognosis of
patients with MS, It occurs early before the systemic venous conges-
tion develops, so it has been shown to be a major determinant of clin-
ical outcome. Severe pulmonary hypertension (PH) is present in about
38% of severe MS cases. Pulmonary vascular disease frequently com-
plicates long standing MS and may signiﬁcantly inﬂuence prognosis.
Non-invasive estimation of pulmonary vascular resistance (PVR) cor-
relates strongly with invasive measures at both normal and elevated
pulmonary pressures.
Objectives: Assess the eﬀects of successful PMC on PVR and RV func-
tions, immediately and after 6 month using new Doppler echocardio-
graphic indices.
Patient and methods: 50 consecutive patients; 45 females (90%) & 5
males (10%) with isolated moderate and severe rheumatic MS under-
went successful PMC. All of the following parameters were measured
before PMC, Immediately after PMC and after 6 months of PMC
using transthoracic echocardiography: Mitral valve area (MVA), peak
diastolic pressure gradient (PDPG), mean diastolic pressure gradient
(MDPG), pulmonary acceleration time (PAT), mean pulmonary
artery pressure (MPAP), tricuspid regurge velocity (TRV), right ven-
tricular systolic pressure (RVSP), right ventricular ejection fraction
(RVEF), right ventricular outﬂow time velocity integral (RVOTTVI),
right ventricular outﬂow tract fractional shortening (RVOTfs), tricus-
pid annular plane systolic excursion (TAPSE) and pulmonary vascu-
lar resistance (PVR) was calculated as PVR= TRVm/s/TVIRVOT
cm x 10+ 0.16.
Conclusions: PMC has a very favorable impact on progressive and sus-
tained improvement of RV functions, regression of pulmonary artery
pressure and recovery of PVR (measured non-invasively) on short term
and after 6 months of follow up. Regression of TRV was strong pre-
dictor for recovery of PVR and RVSP while improvement of RVOTFS
was a strong predictor of recovery of RVEF.
http://dx.doi.org/10.1016/j.ehj.2013.12.035
Impact of fenestration creation on managing patients with protein loosing
enteropathy complicating Fontan procedure
Mashail Alobaidan, Jasim Abdulhameed
Devision of Pediatric Cardiology, Prince Sultan Cardiac Center-
Armed Force hospital, Riyadh, Saudi Arabia.
Introduction: Protein loosing enteropathy (PLE) is well known compli-
cation following Fontan procedure and one way of managing such
complication is to create fenestration if it is not present or enlarging
it if it is small to reduce the Fontan pressure and reduce venous con-
gestion which end up by intestinal protein loss.
Aim: To evaluate the eﬀect of such procedure in our population.
Method: From February 2006 through October 2011 9 patients who
underwent fenestration creation due to development of PLE was
assessed in regard to clinical, laboratory result and hemodynamic eﬀect
prior and post procedure.
Result: Median age is 7 years(4–21) , median weight is 23 kg (15–52),
male: female ratio is 3.5:1 ( male & 2 female), median saturation
pre and post procedure was 93% and 82% respectively, median
albumin pre and post procedure was 18 gm/dl and 31 gm/dl during
the ﬁrst 2 wks and 36 gm/dl thereafter, median pulmonary artery
pressure before and after was 25 mmhg ( 17–32 mmhg) and
16 mmhg (14–19 mmhg), transpulmonary pressure gradient reduced
from a median of 11 mmhg to 5 mmhg, No immediate deaths , 2
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